Prieto I, Gómez de Segura I A, García Grande A, García P, Carralero I, de Miguel E
Experimental Surgery Service, La Paz Hospital, Madrid, Spain.
Rev Esp Enferm Dig. 1998 Mar;90(3):163-73.
Radiation enteritis is a common occurrence after radiotherapy in patients with abdominal tumors. Growth hormone may modify the response of the intestinal mucosa to radiation through its effects on the cell cycle or by increasing cell mass. The aim of this study is to determine the effects of growth hormone in the radiation-induced morphoproliferative changes in the intestinal mucosa.
An intestinal mucosal lesion was induced in adult male Wistar rats by means of abdominal irradiation with a lethal dose (LD50) of 1200 cGy. All animals received treatment with either saline or growth hormone for 7 days after irradiation. The animals were sacrificed on day 7. Body weight was determined the morphoproliferative status of the intestinal mucosa was assessed and the disaccharidase activity was measured.
Growth hormone reduced body weight loss and increased mucosal length in irradiated rats. Mucosal proliferation was incremented in both irradiated and nonirradiated growth hormone-treated rats. Disaccharidase activity levels were similar to or higher than control values in all treated groups.
Administration of growth hormone to irradiated rats reduces intestinal injury, probably as a consequence of an earlier recovery of intestinal morphology and functional status.
放射性肠炎是腹部肿瘤患者放疗后常见的并发症。生长激素可能通过影响细胞周期或增加细胞量来改变肠黏膜对辐射的反应。本研究的目的是确定生长激素对辐射诱导的肠黏膜形态增殖变化的影响。
采用1200 cGy的致死剂量对成年雄性Wistar大鼠进行腹部照射,诱导肠黏膜损伤。所有动物在照射后接受生理盐水或生长激素治疗7天。在第7天处死动物,测定体重,评估肠黏膜的形态增殖状态,并测量双糖酶活性。
生长激素可减轻照射大鼠的体重减轻,并增加黏膜长度。照射和未照射的生长激素治疗大鼠的黏膜增殖均增加。所有治疗组的双糖酶活性水平与对照值相似或更高。
给照射大鼠施用生长激素可减轻肠道损伤,这可能是肠道形态和功能状态较早恢复的结果。